Earth Science Tech (ETST) Other Accumulated Expenses (2022 - 2023)
Earth Science Tech (ETST) posted Other Accumulated Expenses of $33525.0 for Q4 2023, up 708.61% on a QoQ basis from $4146.0 in Q1 2023.
Earth Science Tech (ETST) Other Accumulated Expenses (2022 - 2023) Analysis & Trends
Earth Science Tech's Other Accumulated Expenses history runs 2 years deep, the most recent figure standing at $33525.0 for Q4 2023.
- Quarterly Other Accumulated Expenses changed N/A year-over-year to $33525.0 in Q4 2023, while the trailing twelve-month figure through Dec 2023 was $33525.0 (changed N/A YoY) and the FY2023 annual result came in at $4146.0, up 118.79% from the prior year.
- Other Accumulated Expenses was $33525.0 for Q4 2023 at Earth Science Tech, up from $4146.0 in the prior quarter.
- Across five years, Other Accumulated Expenses topped out at $33525.0 in Q4 2023 and bottomed at $1895.0 in Q1 2022.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 89.28 Bn | 87.42 Bn | - |
| 2 | Teva Pharmaceutical Industries | 35.97 Bn | 32.23 Bn | 1.97 Bn |
| 3 | Zoetis | 32.42 Bn | 30.48 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 27.48 Bn | 23.42 Bn | 4.39 Bn |
| 5 | United Therapeutics | 22.89 Bn | 20.73 Bn | 648.10 Mn |
| 6 | RedHill Biopharma | 22.11 Bn | 22.11 Bn | - |
| 7 | Viatris | 20.44 Bn | 18.64 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.76 Bn | 16.44 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.62 Bn | 12.19 Bn | 785.00 Mn |
| 10 | Earth Science Tech | 32.24 Mn | 30.08 Mn | 6.27 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | 33,525.00 |
| Mar 31, 2023 | 4,146.00 |
| Mar 31, 2022 | 1,895.00 |